Concepedia

Steven Lockton

SL

14

Publications

1.6K

Citations

14

H-Index

2004

Active since

Affiliations

Prometheus Biosciences (United States)(Current)

University of California, Irvine

Regulus Therapeutics (United States)

The University of Texas Southwestern Medical Center

Steven Lockton is an author at Prometheus Biosciences (United States) specializing in medicine, immunology, and autoimmunity.

Top concepts

Publications per year

2004–2019

14

Publications

14

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

Shui-Long Wang, Linda Ohrmund, Scott Hauenstein et al. · Journal of Immunological Methods · 2012 · 203 citations · Full text

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

Sachin Hajarnis, Ronak Lakhia, Matanel Yheskel et al. · Nature Communications · 2017 · 195 citations · Full text

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Edmund C. Lee, Tania Valencia, Charles Allerson et al. · Nature Communications · 2019 · 185 citations · Full text

Plant conserved non-coding sequences and paralogue evolution

Steven Lockton, Brandon S. Gaut · Trends in Genetics · 2004 · 164 citations

, , +9

Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy

Andrés Yarur, Maddie Kubiliun, Frank Czul et al. · Clinical Gastroenterology and Hepatology · 2015 · 157 citations · Full text

, , +8

Rows per page

1–5 of 14